| scholarly article | Q13442814 |
| P50 | author | Michael Frese | Q42703952 |
| Sabine Mihm | Q92209240 | ||
| Ralf Bartenschlager | Q20664754 | ||
| Volker Lohmann | Q37839024 | ||
| P2093 | author name string | Nicole Krieger | |
| Otto Haller | |||
| Kerstin Barth | |||
| Verena Schwärzle | |||
| P2860 | cites work | Peginterferon alfa-2a in patients with chronic hepatitis C. | Q43001243 |
| Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis | Q43001248 | ||
| Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway | Q43030367 | ||
| The natural history of chronic hepatitis C in haemophiliacs | Q44294102 | ||
| Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection | Q45740583 | ||
| Human immunodeficiency and hepatitis C virus coinfection influenced by interferon-gamma | Q45741871 | ||
| gp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-gamma production | Q45756888 | ||
| Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury | Q45761268 | ||
| An antiviral mechanism of nitric oxide: inhibition of a viral protease. | Q54104975 | ||
| Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection | Q56951258 | ||
| Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon | Q57275922 | ||
| Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein | Q22010192 | ||
| Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines | Q27469636 | ||
| Characterization of cell lines carrying self-replicating hepatitis C virus RNAs | Q27469765 | ||
| Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation | Q27469769 | ||
| Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations | Q27469794 | ||
| Effect of alpha interferon on the hepatitis C virus replicon | Q27469963 | ||
| Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection | Q27477843 | ||
| Efficient initiation of HCV RNA replication in cell culture | Q27860520 | ||
| Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line | Q27860561 | ||
| Analysis of successful immune responses in persons infected with hepatitis C virus | Q27860698 | ||
| 1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase | Q28333967 | ||
| Cellular responses to interferon-gamma | Q29618567 | ||
| Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures | Q29618978 | ||
| Analysis of a successful immune response against hepatitis C virus | Q29619507 | ||
| Replication of hepatitis C virus | Q29620645 | ||
| Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C | Q29620791 | ||
| Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production | Q33777676 | ||
| Cytokine-mediated control of viral infections | Q33984178 | ||
| Noncytolytic control of viral infections by the innate and adaptive immune response | Q34178107 | ||
| How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. | Q34250843 | ||
| Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. | Q36368523 | ||
| Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice | Q36404225 | ||
| Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. | Q37380089 | ||
| Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals | Q37694736 | ||
| Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase | Q40594605 | ||
| Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection | Q40836214 | ||
| Regulation of beta2-microglobulin expression in different human cell lines by proinflammatory cytokines | Q40928618 | ||
| Characterization of three novel monoclonal antibodies against hepatitis C virus core protein | Q41220880 | ||
| Hepatitis C: the clinical spectrum of disease | Q41598735 | ||
| The double-stranded RNA-dependent protein kinase PKR: structure and function | Q41614652 | ||
| L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. | Q42275426 | ||
| Interferon-induced gene expression and signaling in human hepatoma cell lines | Q42496616 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis C virus | Q708693 |
| hepatitis C | Q154869 | ||
| P304 | page(s) | 694-703 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs | |
| P478 | volume | 35 |
| Q35612409 | A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection |
| Q45392520 | A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection. |
| Q40339062 | Activation of Vgamma9Vdelta2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication |
| Q40409455 | Activation of interferon-stimulated response element in huh-7 cells replicating hepatitis C virus subgenomic RNA. |
| Q29619722 | Adaptive immune responses in acute and chronic hepatitis C virus infection |
| Q28650908 | Advanced molecular surveillance of hepatitis C virus |
| Q38174262 | Alternative interferons and immunomodulators in the treatment of hepatitis C. |
| Q34039791 | An integrated approach identifies IFN-regulated microRNAs and targeted mRNAs modulated by different HCV replicon clones |
| Q24316159 | Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector |
| Q27473083 | Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons |
| Q42991703 | Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein |
| Q43604476 | Antiviral therapy for hepatitis C |
| Q33436431 | Arabinoxylan rice bran (Biobran) suppresses the viremia level in patients with chronic HCV infection: A randomized trial. |
| Q27486090 | Blockade of virus infection by human CD4+ T cells via a cytokine relay network |
| Q39311520 | CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway |
| Q27488358 | CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes |
| Q33718778 | CD8(+) T-Cell Responses in Acute Hepatitis C Virus Infection. |
| Q34172369 | Characterisation of vaccine-induced, broadly cross-reactive IFN-γ secreting T cell responses that correlate with rapid protection against classical swine fever virus |
| Q40505925 | Combination of Adt-O1Manisa and Ad5-boIFNλ3 induces early protective immunity against foot-and-mouth disease in cattle |
| Q27488834 | Combined antiviral activity of interferon-α and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing |
| Q27472908 | Comparative Analysis of Anti-Hepatitis C Virus Activity and Gene Expression Mediated by Alpha, Beta, and Gamma Interferons |
| Q92310009 | Comparative Evaluation of T-Cell Immune Response to BTV Infection in Sheep Vaccinated with Pentavalent BTV Vaccine When Compared to Un-Vaccinated Animals |
| Q55311655 | Comparison of Interferon-Gamma (IFNG) +874 T/A Single Nucleotide Polymorphism in Hepatitis C Virus Infected Patients and Non-Infected Controls in Mashhad, Iran. |
| Q45877387 | Constant and steady transgene expression of interferon-γ by optimization of plasmid construct for safe and effective interferon-γ gene therapy |
| Q35543288 | Cross-genotype immunity to hepatitis C virus |
| Q35588125 | Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C. |
| Q43040043 | Cytokine gene polymorphisms in hepatitis C virus-related oral lichen planus. |
| Q27485424 | Cytopathic and Noncytopathic Interferon Responses in Cells Expressing Hepatitis C Virus Subgenomic Replicons |
| Q36086311 | DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture |
| Q27478298 | Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C |
| Q30389411 | Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses |
| Q50575151 | Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C. |
| Q34163327 | Differential transcriptional responses to interferon-alpha and interferon-gamma in primary human hepatocytes |
| Q27472675 | Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line |
| Q27473218 | Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication |
| Q35091447 | Does nitric oxide play a pathogenic role in hepatitis C virus infection? |
| Q38967796 | Downregulation of inducible nitric oxide synthase (iNOS) expression is implicated in the antiviral activity of acetylsalicylic acid in HCV-expressing cells. |
| Q40140935 | Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons |
| Q45361438 | Enhanced proinflammatory cytokine activity during experimental bluetongue virus-1 infection in Indian native sheep |
| Q31146715 | Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro |
| Q29618976 | Evasion of intracellular host defence by hepatitis C virus |
| Q28830384 | Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication |
| Q83874872 | Expression of Toll-like receptors and their association with cytokine responses in peripheral blood mononuclear cells of children with acute rotavirus diarrhoea |
| Q40519414 | Expression of bioactive human interferon-gamma in transgenic rice cell suspension cultures |
| Q33257453 | Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication |
| Q37964746 | Failure of innate and adaptive immune responses in controlling hepatitis C virus infection |
| Q36635544 | Flying under the radar: the immunobiology of hepatitis C. |
| Q27489107 | Focal Distribution of Hepatitis C Virus RNA in Infected Livers |
| Q34984147 | Future therapy of hepatitis C. |
| Q33754953 | Gamma interferon-dependent, noncytolytic clearance of sindbis virus infection from neurons in vitro |
| Q97885926 | HCV Replicon Systems: Workhorses of Drug Discovery and Resistance |
| Q39174701 | HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis. |
| Q35251129 | Hantaan virus infection induces both Th1 and ThGranzyme B+ cell immune responses that associated with viral control and clinical outcome in humans |
| Q40038615 | Hepatic immunopathology during occult hepacivirus re-infection |
| Q35572052 | Hepatitis C pathogenesis: Mechanisms of viral clearance and liver injury |
| Q57160237 | Hepatitis C vaccines |
| Q35802129 | Hepatitis C virus NS3/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses [corrected] |
| Q33944512 | Hepatitis C virus and alcohol |
| Q57295205 | Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development |
| Q36326835 | Hepatitis C virus comes full circle: production of recombinant infectious virus in tissue culture |
| Q40241920 | Hepatitis C virus genotype 1b chimeric replicon containing genotype 3 NS5A domain |
| Q36935539 | Hepatitis C virus infection and apoptosis |
| Q42985481 | Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees |
| Q34988243 | Hepatitis C virus replicons: potential role for drug development |
| Q35147050 | Hepatitis C virus therapies: current treatments, targets and future perspectives |
| Q36619978 | Hexabromocyclododecane and tetrabromobisphenol A alter secretion of interferon gamma (IFN-γ) from human immune cells |
| Q27487445 | Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus |
| Q35730979 | Host factors and failure of interferon-alpha treatment in hepatitis C virus |
| Q52651001 | Identification of nucleotides in the 5'UTR and amino acids substitutions that are essential for the infectivity of 5'UTR-NS5A recombinant of hepatitis C virus genotype 1b (strain Con1). |
| Q42981451 | Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. |
| Q37178225 | Immune responses during acute and chronic infection with hepatitis C virus |
| Q44082596 | Immune-based therapy for chronic hepatitis C. |
| Q30371832 | Immunotherapy for HCV infection: next steps. |
| Q37078196 | Impact of host responses on control of hepatitis C virus infection in Chinese blood donors |
| Q36023204 | Increased protection from vaccinia virus infection in mice genetically prone to lymphoproliferative disorders |
| Q40416418 | Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon |
| Q27489517 | Inhibition of Intrahepatic Gamma Interferon Production by Hepatitis C Virus Nonstructural Protein 5A in Transgenic Mice |
| Q27023055 | Innate immune responses in hepatitis C virus infection |
| Q45325497 | Interaction and Mutual Activation of Different Innate Immune Cells Is Necessary to Kill and Clear Hepatitis C Virus-Infected Cells |
| Q27473349 | Interference of hepatitis C virus RNA replication by short interfering RNAs |
| Q34328120 | Interferon type I gene expression in chronic hepatitis C. |
| Q50550271 | Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI). |
| Q40211546 | Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics |
| Q40418675 | Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation |
| Q37338989 | Interferons and their use in persistent viral infections |
| Q42995359 | Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection |
| Q37683158 | Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees |
| Q40000685 | Isolation and gene analysis of interferon alpha-resistant cell clones of the hepatitis C virus subgenome |
| Q40417690 | JAK-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa. |
| Q27469456 | Lambda interferon inhibits hepatitis B and C virus replication |
| Q37326768 | Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases |
| Q27472673 | Liver-directed gamma interferon gene delivery in chronic hepatitis C. |
| Q40472175 | Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice. |
| Q29619805 | Mechanism of action of interferon and ribavirin in treatment of hepatitis C |
| Q36989534 | Mechanisms of Disease: HCV-induced liver injury |
| Q40336636 | Mechanistic link between the anti-HCV effect of interferon gamma and control of viral replication by a Ras-MAPK signaling cascade |
| Q27485119 | Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection |
| Q41452324 | Methylene Blue Attenuates iNOS Induction Through Suppression of Transcriptional Factor Binding Amid iNOS mRNA Transcription |
| Q27486435 | Microarray analysis identifies a common set of cellular genes modulated by different HCV replicon clones |
| Q55400314 | Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy. |
| Q35748893 | Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication. |
| Q43047076 | Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo |
| Q34344742 | Natural killer cells inhibit hepatitis C virus expression |
| Q27488357 | Natural killer cells suppress full cycle HCV infection of human hepatocytes |
| Q40229262 | Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3. |
| Q35628143 | New therapies for chronic hepatitis C virus infection |
| Q35105724 | New therapies on the horizon for hepatitis C: are we close? |
| Q27477758 | Novel Alpha Interferon (IFN- ) Variant with Improved Inhibitory Activity against Hepatitis C Virus Genotype 1 Replication Compared to IFN- 2b Therapy in a Subgenomic Replicon System |
| Q29620681 | Novel insights into hepatitis C virus replication and persistence |
| Q34860648 | Parenchymal expression of CD40 exacerbates adenovirus-induced hepatitis in mice. |
| Q80585608 | Pathogenesis of HIV-HCV Coinfection |
| Q38845669 | Prednisolone does not affect direct-acting antivirals against hepatitis C, but inhibits interferon-alpha production by plasmacytoid dendritic cells. |
| Q36233831 | Prospects for a vaccine against the hepatitis C virus |
| Q27472670 | Quantitative Analysis of the Hepatitis C Virus Replication Complex |
| Q35842500 | Recent developments in target identification against hepatitis C virus |
| Q34390854 | Recombinant interferon-γ lentivirus co-infection inhibits adenovirus replication ex vivo |
| Q40458556 | Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation. |
| Q39273416 | Regulation of hepatitis C virus replication and gene expression by the MAPK-ERK pathway. |
| Q34748063 | Regulation of hepatocyte fate by interferon-γ. |
| Q30414152 | Regulation of host innate immunity by hepatitis C virus: crosstalk between hepatocyte and NK/DC |
| Q27477667 | Replication and IRES-Dependent Translation Are Both Affected by Core Coding Sequences in Subgenomic GB Virus B Replicons |
| Q36058642 | Replicon cell culture system as a valuable tool in antiviral drug discovery against hepatitis C virus |
| Q27478031 | Repression of Interferon Regulatory Factor 1 by Hepatitis C Virus Core Protein Results in Inhibition of Antiviral and Immunomodulatory Genes |
| Q35817615 | Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. |
| Q37362240 | Role of viral and host factors in interferon based therapy of hepatitis C virus infection |
| Q33719537 | SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells |
| Q37438095 | Screening and Identification of an H-2Kb-Restricted CTL Epitope within the Glycoprotein of Hantaan Virus |
| Q36004251 | Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B |
| Q35725505 | Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C |
| Q40250791 | Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. |
| Q27470232 | Stealth and cunning: hepatitis B and hepatitis C viruses |
| Q27023059 | Success of antiviral therapy in chronic hepatitis C infection relates to functional status of myeloid dendritic cells |
| Q43000510 | Successful treatment with novel triple drug combination consisting of interferon-gamma, interferon alfacon-1, and ribavirin in a nonresponder HCV patient to pegylated interferon therapy |
| Q40480541 | T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus |
| Q37683966 | Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liver. |
| Q34347862 | Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment |
| Q24632380 | The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A |
| Q45362053 | The long and the short of interferon-gamma-inducible protein 10 in hepatitis C virus infection. |
| Q35105687 | Tissue culture and animal models for hepatitis C virus |
| Q36758665 | Treating hepatitis C in African Americans |
| Q38783715 | Type I and type II interferon responses in two human liver cell lines (Huh-7 and HuH6). |
| Q96428641 | Type I hypersensitivity is induced in cattle PBMC during Bluetongue virus Taiwan isolate infection |
| Q27481027 | Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction |
| Q98771952 | Use of IFN-Based Biotherapeutics to Harness the Host Against Foot-And-Mouth Disease |
| Q64122751 | Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection |
| Q27473001 | Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease |
| Q40487547 | cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells |
| Q40178866 | p21-activated kinase 1 is activated through the mammalian target of rapamycin/p70 S6 kinase pathway and regulates the replication of hepatitis C virus in human hepatoma cells |
Search more.